Cegedim SA

France · www.cegedim.com · 22 vendors

Resilience scores

Technology vendors

Services catalogue

1 service in catalogue across 1 category; runs on 22 sub-vendors.

Insights

Last updated 2026-07-27 · revision 1

22 direct vendors, 242 subvendors

Direct vendors by controlling owner country (sample)

Subvendors by controlling owner country (sample)

Migration Readiness: 9/10

Assessed by AI based on technology stack characteristics (cloud-native vs legacy, containerization, microservices), regulatory environment, data residency requirements, financial stability, and vendor lock-in risks. The score ranges from 0-10, where higher scores indicate better readiness for technology migration.

Cegedim SA exhibits very high migration readiness, largely due to its core business as a sovereign cloud provider and managed services expert. The company's 'cegedim.cloud' offering, with SecNumCloud qualification and HDS certification, signifies deep internal expertise in cloud infrastructure, migration strategies, and managing highly regulated environments. This means Cegedim SA possesses the technical capabilities and operational knowledge to manage complex migrations, likely leveraging its own robust cloud platform for internal systems. The high regulatory environment (HDS, SecNumCloud) is a significant factor, but Cegedim's internal mastery of these compliance requirements for its own cloud services positions them uniquely to navigate such complexities during migration. Data residency requirements, while not explicitly stated, are implicitly addressed by their French sovereign cloud, which is crucial for healthcare data. The contradictory 'Total Vendors: 0' versus 'Vendor Geographic Diversity: 6 unique countries' makes assessing external vendor lock-in challenging. However, given Cegedim's role as a cloud provider and likely self-hosting of critical applications, external vendor lock-in for core infrastructure is expected to be minimal, further boosting migration readiness. The absence of specific details on internal architectural patterns (e.g., microservices, containerization) for their own applications is a minor gap, but their cloud expertise suggests familiarity with modern cloud-native approaches. Financial stability data is also missing, which could impact the ability to fund large-scale migrations.

Compliance

12 in-scope frameworks identified; showing 3.

HIPAA (source) — Assessment Required

HIPAA risk is Medium because: (1) Cegedim has US operations through subsidiaries and provides pharmaceutical data and health technology services that may extend to US clients; (2) Cegedim Health Data and other subsidiaries may process data from US-based pharmaceutical companies or health organizations; (3) if Cegedim acts as a Business Associate for US-covered entities, HIPAA BAAs and technical safeguards are required; (4) however, Cegedim's primary market is Europe and its core health data hosting (HDS) is France-specific, reducing the likelihood of direct HIPAA applicability compared to a US-headquartered health IT company. The risk is not Low because the pharmaceutical data services (GERS, drug distribution statistics) and potential US client relationships create genuine HIPAA exposure that requires formal assessment.

Evidence: https://www.cegedim.com/solutions/Pages/healthcare-companies.aspx, https://www.cegedim-health-data.com/solutions/, https://www.cegedim.com/contact/Pages/Contact-worldwide.aspx

HDS — Compliant

Risk is Low because Cegedim holds HDS V2 certification covering all 6 HDS activities (both 'Hébergeur d'Infrastructure physique' and 'Hébergeur Infogéreur'), which is the most comprehensive HDS certification possible. HDS has been mandatory in France since 2019 for any entity hosting health data on behalf of healthcare professionals or health insurance organizations. Cegedim has held HDS accreditation since 2009 (predating the current certification regime), demonstrating long-standing compliance. The risk is not zero because HDS certification requires annual surveillance audits and triennial recertification, and any lapse would immediately create legal non-compliance for Cegedim's health data hosting services.

Evidence: https://cegedim.cloud/wp-content/uploads/2025/05/certificat-HDS_cegedim-cloud.pdf, https://www.cegedim.com/about-us/quality/Pages/quality.aspx, https://www.cegedim.com/solutions/Pages/default.aspx

ISO 50001 — Compliant

Risk is Low because cegedim.cloud holds ISO 50001:2018 certification, demonstrating a systematic approach to energy management. This is a voluntary certification but demonstrates environmental responsibility and compliance with energy efficiency best practices. The EU Energy Efficiency Directive and French energy regulations are addressed through this certification.

Evidence: https://cegedim.cloud/wp-content/uploads/2026/04/Certification-ISO-50001_cegedim-cloud.pdf, https://cegedim.cloud/wp-content/uploads/2025/01/Label-code-of-conduct-Datacenter-EB4-cegedim.cloud_.pdf, https://www.cegedim.com/about-us/quality/Pages/quality.aspx

Financials

Three-year financials

Financial Resilience Score: 6/10

Cegedim demonstrates moderate financial resilience, supported by a recurring, subscription-heavy software revenue model in mission-critical healthcare, insurance, and e-invoicing verticals. Adjusted EBITDA margins have expanded steadily from 17.7% in 2023 to 20.7% in 2025, and adjusted operating income grew 25% in 2025 to €49.4M. The Group returned to net profitability in 2025 (€9.4M) after two consecutive years of losses driven largely by one-off items (deferred tax write-downs, UK impairments, restructuring). Liquidity is solid with €92.3M cash at year-end 2025, operating cash flow of €152M, and leverage covenants comfortably met (1.04x vs <2.5x limit). However, resilience is tempered by several structural risks. The Healthcare Professionals segment posted an adjusted operating loss of €9.3M in 2025, requiring a workforce restructuring plan in the French pharmacy business. The UK INPS subsidiary was placed under administration in December 2024 and divested in 2025. An ongoing French tax dispute involves €23M already paid to authorities and a €20.1M receivable, with an unfavorable ruling posing a P&L (though not cash) risk. Revenue growth is decelerating, with only >2% like-for-like guidance for 2026, and the small-cap transfer to Euronext Growth Paris in September 2025 reduces market profile. Overall, the family-controlled ownership provides long-term stability, regulatory tailwinds from mandatory French e-invoicing (phase 1 in September 2026) offer growth catalysts, and margin trajectory is favorable. But loss-making sub-segments, high R&D capitalization, floating-rate debt exposure, and unresolved litigation prevent a higher score.

Key strengths: Recurring, subscription-heavy software revenue model in mission-critical verticals, Adjusted EBITDA margin expansion from 17.7% (2023) to 20.7% (2025), Strong liquidity: €92.3M cash and €152M operating cash flow in 2025, Covenant compliance with leverage at 1.04x vs 2.5x limit, Family/reference shareholder (Labrune) supporting long-term horizon, Regulatory tailwind from mandatory French e-invoicing reform starting September 2026, Return to net profitability in 2025 (€9.4M) after two loss-making years, Sticky healthcare customer base with long switching cycles

Risk factors: Loss-making Healthcare Professionals unit (-€9.3M adj. operating loss in 2025), French pharmacy business restructuring (€7.4M charge, ~100 positions cut), UK INPS subsidiary placed under administration in December 2024, Ongoing French tax dispute with €23M paid and €20.1M receivable at risk, Unresolved Euris unfair competition litigation with no provision set, Interest-rate sensitivity on floating-rate borrowings, Small-cap illiquidity after transfer to Euronext Growth Paris in September 2025, High R&D capitalization (€48M amortized in 2025), Modest revenue growth outlook (>2% like-for-like for 2026), Revenue decline of -0.8% in 2025 driven by INPS deconsolidation and pharmacy weakness

Revenue by product/service

Signed-in users can see whether their own company is exposed to this vendor's disruption, plus the full sub-vendor list and country breakdowns, every in-scope compliance framework plus gaps and next steps, and alerts when any of it changes.

View the full interactive report